Search research articles
Contact Us
Filters
Showing results (41-50 of 112) with videos related to
Page
of 12
Sort By:
Blood
|
June 1, 1980
Factor VIII-related protein circulates in normal human plasma as high molecular weight multimers
L W Hoyer, J R Shainoff
Clinical Immunology and Immunopathology
|
May 1, 1982
Immunologic studies of antihemophilic factor (AHF, VIII:C). VI. Characterization of antigenic determinants using human antibodies
M S Gawryl, L W Hoyer
Blood
|
November 1, 1982
Inactivation of factor VIII coagulant activity by two different types of human antibodies
M S Gawryl, L W Hoyer
Blood
|
August 1, 1980
Pseudothrombocytopenia caused by platelet agglutinins that are reactive in blood anticoagulated with chelating agents
O Onder, A Weinstein, L W Hoyer
Blood
|
September 1, 1984
The idiotypic characteristics of human antibodies to factor VIII
B de la Fuente, L W Hoyer
The Journal of Clinical Investigation
|
June 1, 1989
Molecular basis of factor VIII inhibition by human antibodies. Antibodies that bind to the factor VIII light chain prevent the interaction of factor VIII with phospholipid
M Arai, D Scandella, L W Hoyer
New Istanbul Contribution to Clinical Science
|
May 1, 1980
Mixed mononuclear cell cultures do not elaborate factor VIII
O Onder, J Lazarchick, L W Hoyer
British Journal of Haematology
|
April 1, 1981
Synthesis and release of factor VIII by cultured human endothelial cells
E G Tuddenham, J Lazarchick, L W Hoyer
Vox Sanguinis
|
January 1, 1994
Production of human therapeutic proteins in transgenic animals
L W Hoyer, W N Drohan, H Lubon
The Journal of Clinical Investigation
|
May 1, 1992
Cysteamine enhances the procoagulant activity of Factor VIII-East Hartford, a dysfunctional protein due to a light chain thrombin cleavage site mutation (arginine-1689 to cysteine)
A M Aly, M Arai, L W Hoyer
Page
of 12
Search research articles
Search
Showing results (41-50 of 112) with videos related to
Sort By:
Page
of 12
Blood
|
June 1, 1980
Factor VIII-related protein circulates in normal human plasma as high molecular weight multimers
L W Hoyer, J R Shainoff
Clinical Immunology and Immunopathology
|
May 1, 1982
Immunologic studies of antihemophilic factor (AHF, VIII:C). VI. Characterization of antigenic determinants using human antibodies
M S Gawryl, L W Hoyer
Blood
|
November 1, 1982
Inactivation of factor VIII coagulant activity by two different types of human antibodies
M S Gawryl, L W Hoyer
Blood
|
August 1, 1980
Pseudothrombocytopenia caused by platelet agglutinins that are reactive in blood anticoagulated with chelating agents
O Onder, A Weinstein, L W Hoyer
Blood
|
September 1, 1984
The idiotypic characteristics of human antibodies to factor VIII
B de la Fuente, L W Hoyer
The Journal of Clinical Investigation
|
June 1, 1989
Molecular basis of factor VIII inhibition by human antibodies. Antibodies that bind to the factor VIII light chain prevent the interaction of factor VIII with phospholipid
M Arai, D Scandella, L W Hoyer
New Istanbul Contribution to Clinical Science
|
May 1, 1980
Mixed mononuclear cell cultures do not elaborate factor VIII
O Onder, J Lazarchick, L W Hoyer
British Journal of Haematology
|
April 1, 1981
Synthesis and release of factor VIII by cultured human endothelial cells
E G Tuddenham, J Lazarchick, L W Hoyer
Vox Sanguinis
|
January 1, 1994
Production of human therapeutic proteins in transgenic animals
L W Hoyer, W N Drohan, H Lubon
The Journal of Clinical Investigation
|
May 1, 1992
Cysteamine enhances the procoagulant activity of Factor VIII-East Hartford, a dysfunctional protein due to a light chain thrombin cleavage site mutation (arginine-1689 to cysteine)
A M Aly, M Arai, L W Hoyer
Page
of 12